Correlation Between Qrons and Oncotelic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Qrons and Oncotelic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qrons and Oncotelic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qrons Inc and Oncotelic Therapeutics, you can compare the effects of market volatilities on Qrons and Oncotelic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qrons with a short position of Oncotelic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qrons and Oncotelic Therapeutics.
Diversification Opportunities for Qrons and Oncotelic Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Qrons and Oncotelic is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Qrons Inc and Oncotelic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncotelic Therapeutics and Qrons is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qrons Inc are associated (or correlated) with Oncotelic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncotelic Therapeutics has no effect on the direction of Qrons i.e., Qrons and Oncotelic Therapeutics go up and down completely randomly.
Pair Corralation between Qrons and Oncotelic Therapeutics
If you would invest 16.00 in Qrons Inc on September 14, 2024 and sell it today you would earn a total of 2.00 from holding Qrons Inc or generate 12.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Qrons Inc vs. Oncotelic Therapeutics
Performance |
| Timeline |
| Qrons Inc |
| Oncotelic Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Qrons and Oncotelic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Qrons and Oncotelic Therapeutics
The main advantage of trading using opposite Qrons and Oncotelic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qrons position performs unexpectedly, Oncotelic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncotelic Therapeutics will offset losses from the drop in Oncotelic Therapeutics' long position.| Qrons vs. Northwest Biotherapeutics | Qrons vs. Geron | Qrons vs. Advanced Proteome Therapeutics | Qrons vs. Oxford BioDynamics Plc |
| Oncotelic Therapeutics vs. Processa Pharmaceuticals | Oncotelic Therapeutics vs. Advanced Proteome Therapeutics | Oncotelic Therapeutics vs. Cellectis SA | Oncotelic Therapeutics vs. ChitogenX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |